SHERIDAN, WYOMING - March 13, 2026 - Stellantis N.V. has published the agenda and explanatory notes for its 2026 Annual General Meeting of Shareholders, scheduled for April 14, 2026, in Amsterdam. The agenda matters because the terms of office for several directors expire at the end of the meeting, making board continuity and governance a central item for investors. John Elkann and Robert Peugeot have been proposed for re-election in their current roles, while the board process also signals how the automaker is managing oversight and succession at a time when governance remains material to capital markets and strategic execution.

SHERIDAN, WYOMING - March 13, 2026 - Audi has announced new management appointments in key markets, indicating a leadership change across selected regions in its sales and market organization. While the source material provides only limited detail beyond the headline, the move is commercially relevant because market-level leadership affects distributor oversight, sales execution, customer operations, and local strategic alignment. For a global automotive brand, management changes in priority markets typically signal an effort to sharpen regional accountability and support performance in areas critical to volume, positioning, or market access.

SHERIDAN, WYOMING - March 13, 2026 - Estée Lauder has sued over the use of Jo Malone's name on Zara fragrances, according to the source material, putting a high-profile fragrance branding dispute into the spotlight. The case centers on name usage tied to Jo Malone and products sold through Zara. For beauty, fragrance, and retail operators, the development matters because it highlights how intellectual property and name-rights conflicts can affect product marketing, brand architecture, and risk management in prestige categories.

SHERIDAN, WYOMING - March 13, 2026 - Roche has reported positive Phase II results for petrelintide, an amylin analog being developed for people living with overweight and obesity. According to the company, petrelintide delivered up to 10.7% mean body weight reduction at week 42 compared with 1.7% for placebo, with a p-value of less than 0.001. Roche also said the maximally effective dose showed placebo-like tolerability, with no vomiting cases and no treatment discontinuations due to gastrointestinal adverse events. For the obesity treatment market, the update is relevant because efficacy and tolerability remain central to prescribing, adherence and competitive positioning.

SHERIDAN, WYOMING - March 13, 2026 - ANGA COM has published the conference agenda for its 2026 exhibition and conference, scheduled for May 19-21 in Cologne, Germany, with a program centered on broadband, media and connectivity. The event will feature more than 50 panels and over 200 speakers, including a strong CEO presence from telecom and media companies. The updated agenda matters for operators, vendors, municipalities and investors because it concentrates on network strategy, media business priorities and policy issues that directly affect deployment, service delivery and market positioning. It also expands the practical component of the event through new round tables and a municipalities-focused theme day.

SHERIDAN, WYOMING - March 11, 2026 - It's A 10 Haircare is using its latest company update to frame a broader growth story built around ecommerce scale, category expansion and brand development. The business points to a Shopify 1-Million Order Award while also signaling a move into men's grooming under the leadership of Carolyn Aronson. For operators and brand executives, the combination matters because it links direct-to-consumer execution with portfolio expansion, two factors that can materially affect revenue mix, customer retention and channel strategy.

SHERIDAN, WYOMING - March 9, 2026 - MedTech Europe participated in the first in‑person meeting of the HERA Industrial Cooperation Forum on 6 February 2026, a session in which the European Commission presented HERA's annual workplan and launched two technical working groups. The association used the meeting to underline the operational importance of medical technologies in health responses and to press for practical industry involvement in preparedness exercises. MedTech Europe also flagged the potential burden from additional reporting requirements and said forthcoming work will focus on supply‑chain risks and on supporting development, manufacturing, availability and accessibility of medical countermeasures.

SHERIDAN, WYOMING - December 30, 2025 - CPGIO says it has expanded its digital retail footprint by launching on multiple major marketplaces, positioning the company to support consumer brands with broader omnichannel distribution across a mix of mass, specialty, and B2B wholesale platforms.

Multi-marketplace expansion and timing

The company reported successful launches across Nordstrom, Chewy, Lowe's, Faire, and Best Buy, with the rollout beginning in November 2025. For consumer brands, the announcement signals a continued push toward diversified third-party marketplace presence as a growth lever, particularly as retailers extend marketplace models beyond core categories. For service providers and operators, the business impact typically centers on onboarding speed, catalog and content compliance, inventory synchronization, and the ability to manage pricing and pack-out strategy consistently across channels.

SHERIDAN, WYOMING - December 30, 2025 - ALS Northwest says it increased its financial investment in ALS research throughout 2025, expanding support for new approaches in treatment, prevention, and scientific understanding while joining a multi-organization funding initiative intended to strengthen the overall research pipeline.

Research investment strategy and portfolio focus

ALS Northwest framed its 2025 approach as a scaled-up commitment to research designed to accelerate innovation in amyotrophic lateral sclerosis (ALS). The organization said its efforts span multiple stages of scientific discovery, with an emphasis on enabling new approaches that could move the field forward. For research stakeholders, the operational question is not only how much is invested, but how efficiently funding is converted into validated findings, new targets, and ultimately clinical progress.

SHERIDAN, WYOMING - December 30, 2025 - Public Service Enterprise Group (PSEG) says New York State's comptroller has granted final approval for an extension of PSEG Long Island's operations services agreement with the Long Island Power Authority (LIPA), locking in continued grid-operations responsibilities through the end of 2030.

Contract extension now fully cleared

PSEG said the LIPA Board of Trustees awarded PSEG Long Island a five-year extension of the existing contract on September 25, followed by approval from the New York State attorney general in October and final approval from the comptroller this week. The extension begins January 1, 2026, and runs through December 31, 2030. PSEG Long Island has operated the electric grid on behalf of LIPA since 2014, covering Long Island and the Rockaways.